News

The Food and Drug Administration is considering pulling its authorization of Pfizer’s COVID-19 vaccine for healthy children ...
The U.S. Food and Drug Administration may not renew its authorization for Pfizer's COVID-19 vaccine approved for children ...
AbbVie unveiled a $195 million investment to expand active pharmaceutical ingredient manufacturing in the U.S. Bloomberg reported that BlinkRx, a company that has Donald Trump Jr. on its board, just ...
Pfizer (NYSE: PFE) was a hot stock during the pandemic, but it has been crashing in recent years. The company's COVID vaccine ...
President Donald Trump ordered administration officials to draw up a list of 26 key drugs to develop a stockpile in the ...
The move would add another barrier for parents who want to vaccinate healthy children ahead of the respiratory virus season.
The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...
“We’ve stepped back into the world that we lived in before the [CDC’s vaccine advisory committee] was created,” said Dr.
Most important is anti-blood-clot medicine Eliquis, which is due to lose patent exclusivity in 2026. Eliquis emerged last year as Pfizer’s top-performing drug, having grown rapidly to bring in $7.4bn ...
Schrödinger said it is ending development of the CHC7 inhibitor in blood cancer as both a monotherapy and combination.
In Westport, an Irish town transformed by a pharmaceutical plant that manufactures the world’s Botox, there are fears ...
Robert F. Kennedy Jr.’s ‘Make America Healthy Again’ movement is taking off in red — and blue — states, even as health experts condemn some of his actions.